Live Breaking News & Updates on Translational program grant

Stay informed with the latest breaking news from Translational program grant on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Translational program grant and stay connected to the pulse of your community

UNSW researchers receive more than $5.9m in Cancer Institute NSW grants

UNSW researchers receive more than $5.9m in Cancer Institute NSW grants
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Australia , Australians , Holly-holliday , Vlado-perkovic , Mahdi-zeraati , Amelia-parker , Sean-porazinski , John-pimanda , Cancer-institute-early-career , Career-development-fellowships , Cancer-institute , Translational-program-grant

Scientists show how to attack 'fortress' surrounding pancreatic cancer tumours

Tackling the scar tissue that shields pancreatic tumours from effective drug access is a promising advance in a notoriously hard-to-treat cancer. ...

United-states , Australia , Australians , Australian , American , Phoebe-phillips , David-goldstein , Joshua-mccarroll , Cyrille-boyer , Richard-freeman , George-sharbeen , Australian-pancreatic-cancer-foundation

Scientists show how to attack the 'fortress' surrounding pancreatic cancer tumours – India Education | Latest Education News India | Global Educational News

Share
UNSW medical researchers have found a way to starve pancreatic cancer cells and ‘disable’ the cells that block treatment from working effectively. Their findings in mice and human lab models – which have been 10 years in the making and are about to be put to the test in a human clinical trial – are published today in
Cancer Research, a journal of the American Association for Cancer Research.
“Pancreatic cancer has seen minimal improvement in survival for the last four decades – and without immediate action, it is predicted to be the world’s second biggest cancer killer by 2025,” says senior author Associate Professor Phoebe Phillips from UNSW Medicine & Health.

Sydney , New-south-wales , Australia , United-states , Australians , Australian , American , Phoebe-phillips , David-goldstein , Joshua-mccarroll , Cyrille-boyer , George-sharbeen

Scientists show how to attack the 'fortress' surrounding pancreatic cancer tumors

E-Mail
Credit: UNSW Sydney
UNSW medical researchers have found a way to starve pancreatic cancer cells and 'disable' the cells that block treatment from working effectively. Their findings in mice and human lab models - which have been 10 years in the making and are about to be put to the test in a human clinical trial - are published today in
Cancer Research, a journal of the American Association for Cancer Research.
"Pancreatic cancer has seen minimal improvement in survival for the last four decades - and without immediate action, it is predicted to be the world's second biggest cancer killer by 2025," says senior author Associate Professor Phoebe Phillips from UNSW Medicine & Health.

United-states , Australia , Australians , Australian , American , Phoebe-phillips , David-goldstein , Joshua-mccarroll , Cyrille-boyer , George-sharbeen , Australian-pancreatic-cancer-foundation , University-of-queensland-professor-thomas-davis

UNSW Sydney and the Garvan Institute of Medical Research researchers will lead the program, thanks to a $3.75 million grant from the Cancer Institute NSW

Share
A national clinical trial program will test promising new targeted therapies for pancreatic cancer, one of the deadliest forms of cancers of which more than 3000 cases are diagnosed annually in Australia.
The clinical trial program (MoST–P), led by researchers and clinicians at UNSW and the Garvan Institute, will provide patients with access to either targeted therapies matched to the genomic signature of their individual tumour, or targeted to the tumour environment.
UNSW Dean of Medicine & Health, Professor Vlado Perkovic said the grant could lead to better outcomes for pancreatic cancer patients and more personalised approaches to treatment.
“Our researchers constantly challenge existing knowledge on cancer and are at the forefront of advances in cancer research. The trial announced today is an exciting development in pancreatic cancer research and offers hope for the future for people affected by this terrible disease,” Prof. Perkovic said.

Australia , Sydney , New-south-wales , Australians , Australian , Marina-pajic , David-goldstein , Ursula-sansom-daly , Christina-signorelli , Vlado-perkovic , Catherine-caldon , Paul-timpson

Pancreatic cancer clinical trial program to target genome and scar tissue

UNSW Sydney and the Garvan Institute of Medical Research researchers will lead the program, thanks to a $3.75 million grant from the Cancer Institute...

Australia , Sydney , New-south-wales , Australians , Australian , Marina-pajic , David-goldstein , Ursula-sansom-daly , Christina-signorelli , Vlado-perkovic , Catherine-caldon , Paul-timpson

Pancreatic cancer clinical trial program to target genome an

Date Time
Pancreatic cancer clinical trial program to target genome an
Garvan and UNSW Sydney researchers will establish and lead an innovative pancreatic cancer clinical trial program, thanks to a $3.75 million grant from the Cancer Institute NSW.
A national clinical trial program will test promising new targeted therapy for pancreatic cancer, one of the deadliest forms of cancers of which more than 3000 cases are diagnosed annually in Australia alone.
The clinical trial program (MoST-P), led by researchers and clinicians at UNSW Sydney and the Garvan Institute of Medical Research, will provide patients with access to either targeted therapies matched to the genomic signature of their individual tumour, or targeted to the tumour environment.

Australia , Sydney , New-south-wales , Australians , Australian , Phoebe-phillips , Marina-pajic , David-goldstein , Paul-timpson , David-thomas , Autoimmunity-group , Australian-pancreatic-cancer-foundation